Jeffrey S. Payne,
CPA
Chair, Finance Committee
Chief Financial Officer
Picwell Inc.
Mr. Jeff Payne is Chief Financial Officer of Picwell Inc., a health care information technology company that insurance carriers, brokers, and agents use to help consumers select the best health care plan. Picwell’s Advisory Tool is a predictive decision support tool that asks users a few simple questions to generate scores based on an individual’s projected health care spend, risk tolerance, lifestyle preferences and behavior patterns. Carriers and brokers benefit from reduced churn, lower selling costs, and higher customer satisfaction and retention. Mr. Payne previously served as Chief Financial Officer of Clinical Ink, an eClinical company providing electronic case report forms and patient retention and engagement services. During his tenure as Chief Financial Officer of CRF Health, an international provider of eCOA solutions, CRF Health became the leading provider of eCOA solutions and Mr. Payne oversaw its successful sale to a London-based private equity firm. Mr. Payne held a variety of previous positions: as Chief Financial Officer of TRANZACT, a direct-to-consumer insurance marketing company; Chief Financial Officer and co-founder of The Credo Group, which developed alternative Internet distribution channels for life and health insurance companies and was sold to TRANZACT; and as Chief Financial Officer of DiMark Marketing. Mr. Payne began his career as an auditor with Arthur Andersen and is a Certified Public Accountant and Chartered Global Management Accountant.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China